Spots Global Cancer Trial Database for biib022
Every month we try and update this database with for biib022 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer | NCT00970580 | Non-Small Cell ... | BIIB022 With Pa... | 18 Years - | Biogen | |
| Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC) | NCT00956436 | Hepatocellular ... | BIIB022 Sorafenib | 18 Years - | Biogen | |
| Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC) | NCT00956436 | Hepatocellular ... | BIIB022 Sorafenib | 18 Years - | Biogen | |
| A Study of BIIB022 in Combination With Paclitaxel and Carboplatin in Subjects With Non-Small Cell Lung Cancer | NCT00970580 | Non-Small Cell ... | BIIB022 With Pa... | 18 Years - | Biogen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
